For many decades, scientists have actively pursued development of 'artificial blood'–seeking
a product that is safe, universally compatible with all blood types, and readily available for …

Oxygent™ is a stable concentrated perfluorochemical (PFC) emulsion being developed for
use as a temporary oxygen carrier. In this application, PFC emulsions can be used to …

For almost a century, scientists have been pursuing the development of “artificial blood”—
seeking a product that would be safe, universally compatible with all blood types, and …

Few options are given to the critical care physician to combat tissue hypoxia and its
consequences. Once circulating volume has been restored and the patient has been given …

Perfluorochemicals (PFCs) are highly fluorinated, inert organic compounds that can dissolve
large volumes of O2 and other respiratory gases. PFCs are unreactive in the body and …

Current demands over the blood supply in developed and developing nations will
compound over time. Red cell substitutes have a promising value proposition for transfusion …

Blood transfusion is a remarkably safe, routine clinical procedure. However, the need for
sophisticated blood processing, storage and cross-matching, coupled with increasing …

Alternative oxygen therapeutics are oxygen carriers that can potentially replace red blood
cell transfusion in clinical instances in which banked blood is unavailable or unsafe. Most of …

Perfluorochemical (PFC) emulsions are inert compounds that demonstrate a high solubility
for gases, and are being developed as temporary intravenous oxygen carriers for …

Despite the exhaustive search for an acceptable substitute to erythrocyte transfusion, neither
chemical-based products such as perfluorocarbons nor hemoglobin-based oxygen carriers …